Patents by Inventor Prakrit Jena

Prakrit Jena has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220276171
    Abstract: A method of detecting a condition in a subject comprises the steps of contacting cells of the subject with single-walled carbon nanotubes (SWCNTs), monitoring photoluminescence emitted by SWCNTs internalized into the cells and generating an SW-CNT emission profile, comparing the SWCNT emission profile to a control emission profile for the SWCNTs to produce a result, and determining a likelihood of having the condition in the subject based on the result from the comparing step. Also disclosed is a method for screening agents capable of changing endocytic environment using SWCNTs.
    Type: Application
    Filed: October 8, 2021
    Publication date: September 1, 2022
    Inventors: Prakrit JENA, Daniel A. HELLER, Daniel ROXBURY
  • Publication number: 20210262017
    Abstract: Described herein are novel devices and methods for the optical detection of oligonucleotide binding events for diagnostic, point-of-care, drug screening, and theranostic applications, for example, a robust and customizable system to detect specific DNA and RNA oligonucleotides using a carbon nanotube optical signal.
    Type: Application
    Filed: August 20, 2020
    Publication date: August 26, 2021
    Applicant: Memorial Sloan Kettering Cancer Center
    Inventors: Jackson HARVEY, Daniel HELLER, Prakrit JENA
  • Publication number: 20190383744
    Abstract: A method of detecting a condition in a subject comprises the steps of contacting cells of the subject with single-walled carbon nanotubes (SWCNTs), monitoring photoluminescence emitted by SWCNTs internalized into the cells and generating an SWCNT emission profile, comparing the SWCNT emission profile to a control emission profile for the SWCNTs to produce a result, and determining a likelihood of having the condition in the subject based on the result from the comparing step. Also disclosed is a method for screening agents capable of changing endocytic environment using SWCNTs.
    Type: Application
    Filed: August 22, 2019
    Publication date: December 19, 2019
    Inventors: Prakrit JENA, Daniel A. HELLER, Daniel ROXBURY
  • Patent number: 10401295
    Abstract: A method of detecting a condition in a subject comprises the steps of contacting cells of the subject with single-walled carbon nanotubes (SWCNTs), monitoring photoluminescence emitted by SWCNTs internalized into the cells and generating an SWCNT emission profile, comparing the SWCNT emission profile to a control emission profile for the SWCNTs to produce a result, and determining a likelihood of having the condition in the subject based on the result from the comparing step. Also disclosed is a method for screening agents capable of changing endocytic environment using SWCNTs.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: September 3, 2019
    Assignee: Memorial Sloan Kettering Cancer Center
    Inventors: Prakrit Jena, Daniel A. Heller, Daniel Roxbury
  • Publication number: 20190119734
    Abstract: Described herein are novel devices and methods for the optical detection of oligonucleotide binding events for diagnostic, point-of-care, drug screening, and theranostic applications, for example, a robust and customizable system to detect specific DNA and RNA oligonucleotides using a carbon nanotube optical signal.
    Type: Application
    Filed: April 7, 2017
    Publication date: April 25, 2019
    Applicant: Memorial Sloan Kettering Cancer Center
    Inventors: Jackson HARVEY, Daniel HELLER, Prakrit JENA
  • Publication number: 20170199126
    Abstract: A method of detecting a condition in a subject comprises the steps of contacting cells of the subject with single-walled carbon nanotubes (SWCNTs), monitoring photoluminescence emitted by SWCNTs internalized into the cells and generating an SWCNT emission profile, comparing the SWCNT emission profile to a control emission profile for the SWCNTs to produce a result, and determining a likelihood of having the condition in the subject based on the result from the comparing step. Also disclosed is a method for screening agents capable of changing endocytic environment using SWCNTs.
    Type: Application
    Filed: May 28, 2015
    Publication date: July 13, 2017
    Inventors: Prakrit Jena, Daniel A. Heller, Daniel Roxbury